tiprankstipranks
Trending News
More News >
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN

Supernus Pharmaceuticals (SUPN) Revenue

Compare
537 Followers

Supernus Pharmaceuticals Revenue

Supernus Pharmaceuticals had a revenue of 192.10M in the quarter ending Sep 30, 2025, with 16.11%. This bring the company's revenue in the last twelve months to 681.54M, Decreased 2.47%. In the fiscal year ending Dec 31, 2024, Supernus Pharmaceuticals had annual revenue of 661.82M with 8.94% growth.
Revenue (ttm)
681.54M
Revenue Growth
4.54%
P/S Ratio
4.47
Revenue/Employee
$981,924
Employees
674
Market Cap
$2.96B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
661.82M54.30M+108.94%
Dec 31, 2023
607.52M-59.72M+91.05%
Dec 31, 2022
667.24M87.46M+115.09%
Dec 31, 2021
579.77M59.38M+111.41%
Dec 31, 2020
520.40M127.64M+132.50%
Dec 31, 2019
392.75M-16.14M+96.05%
Dec 31, 2018
408.90M106.66M+135.29%
Dec 31, 2017
302.24M87.23M+140.57%
Dec 31, 2016
215.00M